03:41 PM EDT, 03/10/2025 (MT Newswires) -- Health care stocks were lower late Monday afternoon, with the NYSE Health Care Index shedding 1.4% and the Health Care Select Sector SPDR Fund (XLV) down 0.8%.

The iShares Biotechnology ETF (IBB) declined 0.3%.

In corporate news, Mineralys Therapeutics ( MLYS ) shares surged 55% after it said Monday that lorundrostat met primary endpoints in phase 3 Launch-HTN and phase 2 Advance-HTN trials in people with uncontrolled hypertension or resistant hypertension.